Reduction of BK Viremia in Kidney Transplant Patients (NCT04984902) | Clinical Trial Compass
WithdrawnNot Applicable
Reduction of BK Viremia in Kidney Transplant Patients
Stopped: No participants enrolled due to logistical issues related to COVID-19 with recruiting patients.
Germany0Started 2022-02-01
Plain-language summary
Reduction of BK Viremia by treating kidney transplant patients.
Who can participate
Age range
18 Years – 90 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Kidney transplant patients with a BK-viraemia ≥ 10,000 IU/ml.
. Be ≥ 18 years old and ≤ 90 years old
. Existing hemodialysis access
Exclusion criteria
. Subject is currently participating in another clinical investigation
. Pregnant or nursing subjects and those who plan pregnancy during the clinical investigation follow-up period
. Presence of comorbid conditions, or other medical, social, or psychological conditions that, in the investigator's opinion, could limit the subject's ability to participate in the clinical investigation or to comply with follow-up requirements, or impact the scientific soundness of the clinical investigation results
. Have Child-Pugh Class C cirrhosis
. Have platelet count \<30.000/uL
. Contraindications for heparin sodium for injection
. Subjects demonstrating any contraindication for this treatment as described in the IFU
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in log 10 viral load
Timeframe: At day 0 and the following 3 treatments within five days after beginning with the first treatment.